Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
# Background Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. Clinical practice guidelines recommend maintaining a h...
Saved in:
| Main Authors: | John E. Schneider, Anjani Parikh, Ivana Stojanovic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2018-02-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin resistance in drug naive patients with multiple sclerosis
by: Kostić Smiljana, et al.
Published: (2017-01-01) -
Impact of insulin storage and syringe reuse on insulin sterility in diabetes mellitus patients in Mwanza Tanzania
by: Emmanuel Kimaro, et al.
Published: (2025-02-01) -
Obesity Is Associated with an Increase in Pharmaceutical Expenses among University Employees
by: Julie A. Gazmararian, et al.
Published: (2015-01-01) -
Management of the Insulin Dependant Diabetic
by: P. Rheeder
Published: (1998-01-01) -
Insulin Management for Hypertriglyceridemia in Pregnancy
by: Decui Cheng, et al.
Published: (2023-01-01)